Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Progyny, Inc. (PGNY)
Sector: Healthcare; Industry: Health Information Services

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

PGNY Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-30 TPG Group Holdings (SBS) Advisors, Inc. 10%-Owner Sell 346,961 $61.33 $21,278,955 No
2021-06-25 Schlanger David J Chief Executive Officer Sell 220,002 $59.45 $13,079,686 No
2021-06-23 Bealer Jennifer EVP, General Counsel Sell 1,940 $60.23 $116,844 Yes
2021-06-22 TPG Group Holdings (SBS) Advisors, Inc. 10%-Owner Sell 3,277,647 $59.65 $195,505,994 No
2021-06-21 Livingston Mark S. Chief Financial Officer Sell 23,221 $62.40 $1,448,901 Yes
2021-06-02 Anevski Peter President and COO Sell 2,300 $65.28 $150,144 No
2021-06-03 Schlanger David J Chief Executive Officer Sell 50,000 $62.50 $3,124,908 Yes
2021-06-02 Schlanger David J Chief Executive Officer Sell 100,000 $63.84 $6,383,819 Yes
2021-06-02 Anevski Peter President and COO Sell 39,700 $63.70 $2,528,724 No
2021-05-24 Bealer Jennifer EVP, General Counsel Sell 1,934 $57.79 $111,771 Yes
2021-05-05 Schlanger David J Chief Executive Officer Sell 50,000 $53.21 $2,660,365 Yes
2021-05-06 Anevski Peter President and COO Sell 42,000 $52.40 $2,200,895 No
2021-05-04 Anevski Peter President and COO Sell 42,000 $55.19 $2,318,054 No
2021-04-23 Bealer Jennifer EVP, General Counsel Sell 2,401 $51.47 $123,570 Yes
2021-04-22 Payson Norman Director Sell 10,000 $50.48 $504,832 No
2021-04-15 SEIDENBERG BETH C Director Sell 18,127 $50.32 $912,151 Yes
2021-04-15 KLEINER PERKINS CAUFIELD & BYERS XIII, LLC 10%-Owner Sell 18,127 $50.32 $912,151 Yes
2021-04-15 Greenbaum Lisa EVP, Chief Client Officer Sell 2,353 $50.46 $118,737 Yes
2021-04-15 Payson Norman Director Sell 10,000 $49.94 $499,433 No
2021-04-08 Schlanger David J Chief Executive Officer Sell 36,976 $45.58 $1,685,426 Yes
2021-04-08 Anevski Peter President and COO Sell 33,582 $45.57 $1,530,366 No
2021-04-08 Payson Norman Director Sell 10,000 $45.20 $452,005 No
2021-04-06 Schlanger David J Chief Executive Officer Sell 112,020 $46.10 $5,164,122 Yes
2021-04-06 Anevski Peter President and COO Sell 49,618 $46.08 $2,286,397 No
2021-04-01 Schlanger David J Chief Executive Officer Sell 1,004 $46.19 $46,375 Yes
2021-04-01 Anevski Peter President and COO Sell 800 $46.19 $36,952 No
2021-03-31 Payson Norman Director Sell 10,000 $43.73 $437,266 No
2021-03-25 Payson Norman Director Sell 10,000 $46.71 $467,062 No
2021-03-23 Bealer Jennifer EVP, General Counsel Sell 2,468 $48.54 $119,801 Yes
2021-03-18 Payson Norman Director Sell 10,000 $47.76 $477,569 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.